BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27145868)

  • 1. Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana.
    Oduro-Mensah D; Obeng-Nkrumah N; Bonney EY; Oduro-Mensah E; Twum-Danso K; Osei YD; Sackey ST
    Ann Clin Microbiol Antimicrob; 2016 May; 15():29. PubMed ID: 27145868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Perils of Extended Spectrum
    Parajuli NP; Maharjan P; Joshi G; Khanal PR
    Biomed Res Int; 2016; 2016():1782835. PubMed ID: 28119921
    [No Abstract]   [Full Text] [Related]  

  • 4. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
    J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping.
    Hassan MI; Alkharsah KR; Alzahrani AJ; Obeid OE; Khamis AH; Diab A
    J Infect Dev Ctries; 2013 Aug; 7(8):618-29. PubMed ID: 23949298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of extended spectrum β-lactamase-producing Enterobacteriaceae strains isolated from a tertiary care hospital.
    Jena J; Debata NK; Sahoo RK; Gaur M; Subudhi E
    Microb Pathog; 2018 Feb; 115():112-116. PubMed ID: 29274456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
    Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
    Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamase production and multi-drug resistance among
    Teklu DS; Negeri AA; Legese MH; Bedada TL; Woldemariam HK; Tullu KD
    Antimicrob Resist Infect Control; 2019; 8():39. PubMed ID: 30815254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.
    Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D
    J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
    Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
    Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.
    Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S
    Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.